Ident. | Authors (with country if any) | Title |
---|
000704 (2006) |
David W. Anderson ; Kristin A. Bradbury ; Jay S. Schneider | Neuroprotection in Parkinson models varies with toxin administration protocol |
000731 (2007) |
Jeffrey M. Hausdorff ; Justine Lowenthal ; Talia Herman ; Leor Gruendlinger ; Chava Peretz ; Nir Giladi | Rhythmic auditory stimulation modulates gait variability in Parkinson's disease |
000A42 (2005) |
Catharine A. Winstanley ; Christelle Baunez ; David E. H. Theobald ; Trevor W. Robbins | Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control |
000B82 (2004) |
Eilís Dowd ; Stephen B. Dunnett | Deficits in a lateralized associative learning task in dopamine‐depleted rats with functional recovery by dopamine‐rich transplants |
000B90 (2005) |
Mahmoud M. Iravani ; Sergio Costa ; Ghassan Al-Bargouthy ; Michael J. Jackson ; Bai-Yun Zeng ; Mikko Kuoppam Ki ; Jose A. Obeso ; Peter Jenner | Unilateral pallidotomy in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets exhibiting levodopa‐induced dyskinesia |
000C92 (2006) |
Rossitza Baltadjieva ; Nir Giladi ; Leor Gruendlinger ; Chava Peretz ; Jeffrey M. Hausdorff | Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease |
000F88 (2005) |
Eilís Dowd ; Christelle Monville ; Eduardo M. Torres ; Liang-Fong Wong ; Mimoun Azzouz ; Nicholas D. Mazarakis ; Stephen B. Dunnett | Lentivector‐mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model |
001004 (2009) |
C. Marin ; E. Aguilar ; G. Mengod ; R. Cortés ; J. A. Obeso | Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats |
001182 (2007) |
M. J. Hurley ; P. H. Patel ; M. J. Jackson ; L. A. Smith ; S. Rose ; P. Jenner | Striatal leucine‐rich repeat kinase 2 mRNA is increased in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned common marmosets (Callithrix jacchus) with l‐3, 4‐dihydroxyphenylalanine methyl ester‐induced dyskinesia |
001213 (2008) |
Darcy Litteljohn ; Emily N. Mangano ; Shawn Hayley | Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice |
001293 (2005) |
Galit Yogev ; Nir Giladi ; Chava Peretz ; Shmuel Springer ; Ely S. Simon ; Jeffrey M. Hausdorff | Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding? |
001435 (2005) |
Colum D. Mackinnon ; Ruth M. Webb ; Paul Silberstein ; Steven Tisch ; Peter Asselman ; Patricia Limousin ; John C. Rothwell | Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease |
001670 (2010) |
Esther Florin ; Joachim Gross ; Christiane Reck ; Mohammad Maarouf ; Alfons Schnitzler ; Volker Sturm ; Gereon R. Fink ; Lars Timmermann | Causality between local field potentials of the subthalamic nucleus and electromyograms of forearm muscles in Parkinson’s disease |
001806 (2005) |
Fang Du ; Rui Li ; Yuangui Huang ; Xuping Li ; Weidong Le | Dopamine D3 receptor‐preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons |
001857 (2010) |
Ayse Ulusoy ; Fabia Febbraro ; Poul H. Jensen ; Deniz Kirik ; Marina Romero-Ramos | Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology |
001868 (2008) |
Meir Plotnik ; Nir Giladi ; Jeffrey M. Hausdorff | Bilateral coordination of walking and freezing of gait in Parkinson’s disease |
001915 (2006) |
Rebecca E. Colebrooke ; Trevor Humby ; Patrick J. Lynch ; Daniel P. Mcgowan ; Jing Xia ; Piers C. Emson | Age‐related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease |
001A11 (2010) |
Jens Clausen | Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice |
001A47 (2007) |
Emilie Lacombe ; Carole Carcenac ; Sabrina Boulet ; Claude Feuerstein ; Anne Bertrand ; Annie Poupard ; Marc Savasta | High‐frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l‐3,4‐dihydroxyphenylalanine in dopaminergic denervated rats |
001A57 (2003) |
Carl Rosenblad ; Biljana Georgievska ; Deniz Kirik | Long‐term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system |
001B02 (2009) |
Thibaud Lebouvier ; Tanguy Chaumette ; Sébastien Paillusson ; Charles Duyckaerts ; Stanislas Bruley Des Varannes ; Michel Neunlist ; Pascal Derkinderen | The second brain and Parkinson’s disease |
001B63 (2007) |
Soon S. Park ; Emily M. Schulz ; Daewoo Lee | Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α‐synuclein |
001C07 (2011) |
Maria Papathanou ; Sarah Rose ; Andrew Mccreary ; Peter Jenner | Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6‐OHDA‐lesioned rats |
001C27 (2002) |
Kevin St P. Mcnaught ; P. Shashidharan ; Daniel P. Perl ; Peter Jenner ; C. Warren Olanow | Aggresome‐related biogenesis of Lewy bodies |
001C90 (2009) |
J. Coste ; L. Ouchchane ; L. Sarry ; P. Derost ; F. Durif ; J. Gabrillargues ; S. Hemm ; J. J. Lemaire | New electrophysiological mapping combined with MRI in parkinsonian’s subthalamic region |
001D82 (2007) |
Hyun Jung Park ; Phil Hyu Lee ; Young Whan Ahn ; Yun Jung Choi ; Gwang Lee ; Da-Yong Lee ; Eun S. Chung ; Byung Kwan Jin | Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action |
001E49 (2002) |
Galit Pelled ; Hagai Bergman ; Gadi Goelman | Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease – a functional magnetic resonance imaging study |
001F39 (2009) |
Naroa Ibarretxe-Bilbao ; Carme Junque ; Eduardo Tolosa ; Maria-Jose Marti ; Francesc Valldeoriola ; Nuria Bargallo ; Mojtaba Zarei | Neuroanatomical correlates of impaired decision‐making and facial emotion recognition in early Parkinson’s disease |
002174 (2005) |
Joanna Iczkiewicz ; Sarah Rose ; Peter Jenner | Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat |
002181 (2005) |
Pedro Barroso-Chinea ; Ignacio Cruz-Muros ; María S. Aymerich ; Manuel Rodríguez-Díaz ; Domingo Afonso-Oramas ; José L. Lanciego ; Tomás González-Hernández | Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells |
002192 (2005) |
Mahmoud M. Iravani ; Emilie Syed ; Michael J. Jackson ; Louisa C. Johnston ; Lance A. Smith ; Peter Jenner | A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets |
002293 (2004) |
Elanor C. Hinton ; John A. Parkinson ; Anthony J. Holland ; F. Sergio Arana ; Angela C. Roberts ; Adrian M. Owen | Neural contributions to the motivational control of appetite in humans |
002295 (2010) |
Romulo Fuentes ; Per Petersson ; Miguel A. L. Nicolelis | Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach |
002308 (2005) |
Mahmoud M. Iravani ; Clement C. M. Leung ; Mona Sadeghian ; Claire O. Haddon ; Sarah Rose ; Peter Jenner | The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation |
002320 (2011) |
Saskia Van Stockum ; Michael R. Macaskill ; Daniel Myall ; Tim J. Anderson | A perceptual discrimination task abnormally facilitates reflexive saccades in Parkinson’s disease |
002404 (2011) |
Yuen-Sum Lau ; Gaurav Patki ; Kaberi Das-Panja ; Wei-Dong Le ; S. Omar Ahmad | Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration |
002469 (2009) |
Alice Nieuwboer ; Sarah Vercruysse ; Peter Feys ; Oron Levin ; Joke Spildooren ; Stephan Swinnen | Upper limb movement interruptions are correlated to freezing of gait in Parkinson’s disease |
002538 (2009) |
Tultul Nayyar ; Michael Bubser ; Marcus C. Ferguson ; M. Diana Neely ; J. Shawn Goodwin ; Thomas J. Montine ; Ariel Y. Deutch ; Twum A. Ansah | Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation |
002613 (2003) |
Kati Kühn ; Jennifer Wellen ; Nina Link ; Lyutha Maskri ; Hermann Lübbert ; Christine C. Stichel | The mouse MPTP model: gene expression changes in dopaminergic neurons |
002680 (2005) |
Katsumi Tsuchiya ; Hisao Tajima ; Toyoyasu Kuwae ; Takao Takeshima ; Toshiya Nakano ; Masaharu Tanaka ; Katsuyoshi Sunaga ; Yoko Fukuhara ; Kenji Nakashima ; Eisaku Ohama ; Hideki Mochizuki ; Yoshikuni Mizuno ; Nobuo Katsube ; Ryoichi Ishitani | Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions |
002707 (2007) |
Fabio Blandini ; Giovanna Levandis ; Eleonora Bazzini ; Giuseppe Nappi ; Marie-Therese Armentero | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
002832 (2005) |
Gerlinde A. Metz ; Arthur Tse ; Mark Ballermann ; Lori K. Smith ; Karim Fouad | The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis |
002845 (2010) |
Federica Agosta ; Vladimir S. Kosti ; Sebastiano Galantucci ; Šarlota Mesaroš ; Marina Svetel ; Elisabetta Pagani ; Elka Stefanova ; Massimo Filippi | The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study |
002903 (2005) |
P. M. Carvey ; C. H. Zhao ; B. Hendey ; H. Lum ; J. Trachtenberg ; B. S. Desai ; J. Snyder ; Y. G. Zhu ; Z. D. Ling | 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability |
002A57 (2011) |
Carmen Agustín-Pav N ; John Parkinson ; Mei-See Man ; Angela C. Roberts | Contribution of the amygdala, but not orbitofrontal or medial prefrontal cortices, to the expression of flavour preferences in marmoset monkeys |
002B09 (2011) |
Masayuki Watanabe ; Douglas P. Munoz | Probing basal ganglia functions by saccade eye movements |
002C37 (2009) |
Franz Marxreiter ; Silke Nuber ; Mahesh Kandasamy ; Jochen Klucken ; Robert Aigner ; Ralf Burgmayer ; Sebastien Couillard-Despres ; Olaf Riess ; Jürgen Winkler ; Beate Winner | Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha‐synuclein |
002C74 (2011) |
Beate Winner ; Zacharias Kohl ; Fred H. Gage | Neurodegenerative disease and adult neurogenesis |
002C82 (2005) |
N. L. W. Keijsers ; M. A. Admiraal ; A. R. Cools ; B. R. Bloem ; C. C. A. M. Gielen | Differential progression of proprioceptive and visual information processing deficits in Parkinson's disease |
002D41 (2003) |
Yassine Darbaky ; Claude Forni ; Marianne Amalric ; Christelle Baunez | High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task |
002D94 (2009) |
David A. Price ; Alex A. Martinez ; Alexandre Seillier ; Wouter Koek ; Yolanda Acosta ; Elizabeth Fernandez ; Randy Strong ; Beat Lutz ; Giovanni Marsicano ; James L. Roberts ; Andrea Giuffrida | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |